Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants

NCT06738017 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha 1-Antitrypsin Deficiency

Interventions

DRUG: BMN 349
DRUG: Placebo

Sponsor

BioMarin Pharmaceutical